GreenSense - a DoA lab in a smart card format

ProjectGreenSense - drug sensing in small form factors

Key Areas
GreenSense - drug sensing in small form factors

RISE Acreo and RISE Bioeconomy are proud partners in a new project where paper-based printed electronics, nanocellulose and conducting polymers will be used to create a biosensing platform for rapid testing of Drug-of-Abuse (DoA).

GreenSense - A Sustainable, Wireless, Autonomous Nanocellulosebased Quantitative DoA Biosensing Platform.

The project will integrate printed electronic components such as a new biosensor, NFC communication, energy storage  and display, with a silicon microchip for multi-sensor data processing, autonomy and wireless communication. Functionalized and printable NanoCellulose will be used for printed electronics, encapsulation and as an active component in the functional inks (bioactive, conductive, dielectric, electrochemical, electrochromic). Pilot lines and high throughput, high precision and cost-effective S2S screen-printing and ink-jet printing techniques will be used to produce materials and components at large-scale. With a budget of 8M€ this EU H2020-project is aiming high and has a pan-european consortium.

The final flexible, recyclable and ultra-low power consumption NC-based biosensing platform will be mass producible and, therefore, cost-effective, sustainable and environmentally friendly.

To achieve the targeted objectives described above an international and multidisciplinary consortium has been assembled:

  • LEITAT (Spain)
  • AIT (Austria)
  • MELODEA Ltd (Israel)
  • RISE ACREO (Sweden)
  • ATLAS MEDICAL (Jordan), GENES'INK (France)
  • IMST GMBH (Germany)
  • PRO-ACTIVE (Belgium)
  • PRELONIC (Austria)
  • EMPA (Switzerland)

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 761000. This publication reflects only the author’s views and the European Union is not liable for any use that may be made of the information contained therein.

External homepage: